查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲直接面對消費者的基因測試市場預測至 2030 年 - 區域分析 - 按測試類型、技術和配銷通路
市場調查報告書
商品編碼
1463720

歐洲直接面對消費者的基因測試市場預測至 2030 年 - 區域分析 - 按測試類型、技術和配銷通路

Europe Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 77 Pages | 訂單完成後即時交付

價格

2022年歐洲直接面對消費者的基因檢測市場價值為5.0798億美元，預計到2030年將達到21.0366億美元；預計2022年至2030年CAGR為19.4%。

人們對基因檢測潛在益處的認知不斷增強，推動了歐洲直接面對消費者的基因檢測市場

消費者越來越受到自我好奇心和賦權的驅動，這反映在對提供基因檢測和後續諮詢的服務意識的增強。全世界人民對基因檢測的認知和接受度正在穩步提高。客戶從被動向自主和自我意識的轉變正在推動基因檢測市場的發展。直接面對消費者的基因檢測 (DTC-GT) 固有的可訪問性是一個主要優勢，它使消費者可以免費獲得其基因資訊以及個人化的見解和建議。許多行業都發現尋求客製化產品和體驗的客戶顯著增加，並且為識別和滿足個人需求而付費的意願也增強。

Genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the狀態.基因檢測在醫學各領域的角色正在迅速增強。基因檢測已經在加快診斷速度，並有助於識別具有高復原力疾病遺傳傾向的人。孕前和產前基因檢測可告知潛在患者其遺傳性疾病帶因者狀況，從而幫助他們做出生殖決定。

人們越來越認知到與不同疾病相關的各種表現型的遺傳變異的重要性，預計將進一步促進市場成長。這些測試揭示了一個人是否具有某種特定疾病或相關表現型的遺傳傾向，可以儘早診斷並開始疾病治療。人類基因組的首次定序和基因組定序技術的進步促進了基因組學研究的快速發展。這也導致直接面對消費者的基因檢測成為一項新服務。歐洲直接面對消費者的基因檢測市場影響了許多人，因為這些檢測提供了有關各種健康風險、個人特徵和整體福祉的有效資訊。此外，臨床實驗室人員快速過渡到 DTC-GT 是推動市場的另一個關鍵因素。例如，根據《麻省理工科技評論》的報導，2019 年，約 8%（即近 2,600 萬人）的美國人接受了 DNA 檢測。

因此，人們對基因檢測的認知不斷增強，推動了直接面對消費者的基因檢測市場的發展。

歐洲直接面對消費者的基因檢測市場概述

歐洲直接面對消費者的基因檢測市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。由於人們對基因檢測的認知不斷提高，以及遺傳性疾病和癌症盛行率的上升，預計該區域市場在未來幾年將顯著成長。過去幾年技術的不斷進步為直接面對消費者的基因檢測市場的擴張帶來了無數機會。針對利基治療領域的客製化檢測試劑盒的開發和慢性病盛行率的上升有利於德國直接面對消費者的基因檢測市場。此外，隨著個體基因組定序成本呈指數下降，遺傳學在臨床實踐中變得至關重要。遺傳學為醫生提供了寶貴的症狀前診斷，在某些情況下還提供了分析工具，可用於更有效地管理疾病並採取預防措施。基因組分析工具價格的指數下降也使個人能夠快速、經濟地獲得他們的基因圖譜。

據德國癌症研究中心稱，2022年德國有近69,000名女性和700-800名男性被診斷出乳癌。德國政府宣布計劃將乳癌基因1（BRCA）基因檢測納入國家癌症計劃，該計劃於2008年啟動，旨在確保具有較高乳癌遺傳風險的女性依法有權獲得全面的乳癌基因檢測。查和降低風險的選擇。德國政府越來越注重監管和提高人們對基因測試的認知，促使德國各地採用直接面對消費者的基因測試。

歐洲直接面對消費者的基因檢測市場收入和 2030 年預測（百萬美元）

歐洲直接面對消費者的基因檢測市場區隔

歐洲直接面對消費者的基因測試市場分為測試類型、技術、配銷通路和國家。

根據測試類型，歐洲直接面對消費者的基因測試市場分為血統測試、預測測試、營養基因組學測試、帶因者測試等。 2022 年，血統測驗細分市場佔據最大佔有率。

從技術上來看，歐洲直接面對消費者的基因檢測市場分為全基因組定序、單核苷酸多態性晶片、標靶分析等。 2022年，單核苷酸多態性晶片領域佔據最大佔有率。

根據配銷通路，歐洲直接面對消費者的基因檢測市場分為線上和線下。 2022 年，線上細分市場佔據了更大的佔有率。

根據國家/地區，歐洲直接面對消費者的基因檢測市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲直接面對消費者的基因檢測市場佔據主導地位。

Ancestry Genomics Inc、Myriad Genetics, Inc.、Living DNA Ltd、23andMe Inc 和 Genetic Technologies Ltd 是歐洲直接面對消費者基因檢測市場的一些領先公司。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲直接面對消費者的基因檢測市場格局

  • 概述

第 5 章：歐洲直接面對消費者的基因檢測市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病的發生率不斷上升
    • 提高對基因檢測潛在益處的認知
  • 市場限制
    • 與直接面對消費者的基因檢測相關的高成本和隱私問題
  • 市場機會
    • 單核苷酸多態性 (SNP) 晶片的採用日益廣泛
  • 未來的趨勢
    • 人們對藥物基因學的興趣日益濃厚，遠距醫療的採用也不斷增加
  • 影響分析

第 6 章：直接面對消費者的基因檢測市場 - 歐洲市場分析

  • 歐洲直接面對消費者的基因檢測市場收入，2022 - 2030

第 7 章：歐洲直接面對消費者的基因測試市場 - 收入和 2030 年預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年歐洲直接面對消費者的基因測試市場收入佔有率，按測試類型分類 (%)
  • 血統測試
  • 營養基因組學測試
  • 預測測試
  • 營運商測試
  • 其他

第 8 章：歐洲直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年和 2030 年歐洲直接面對消費者的基因檢測市場收入佔有率（按技術分類）（%）
  • 全基因組定序
  • 單核苷酸多態性晶片
  • 針對性分析
  • 其他

第 9 章：歐洲直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按配銷通路

  • 概述
  • 2022 年和 2030 年歐洲直接面對消費者的基因檢測市場收入佔有率（按配銷通路分類）（%）
  • 線上平台
  • 線下平台

第 10 章：歐洲直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 國家分析

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 餘下的

第 11 章：歐洲直接面對消費者的基因檢測市場-產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章：公司簡介

  • Ancestry Genomics Inc
  • Genetic Technologies Ltd
  • Myriad Genetics, Inc.
  • Living DNA Ltd
  • 23andMe Inc

第 13 章：附錄

Product Code: BMIRE00029623

The Europe direct-to-consumer genetic testing market was valued at US$ 507.98 million in 2022 and is expected to reach US$ 2,103.66 million by 2030; it is estimated to grow at a CAGR of 19.4% from 2022 to 2030.

Increasing Awareness About Potential Benefits of Genetic Testing Fuels the Europe Direct-to-Consumer Genetic Testing Market

Consumers are increasingly driven by self-curiosity and empowerment, reflected by increased awareness of services that offer genetic testing and follow-up counseling. Awareness and acceptance of genetic testing is steadily increasing among the population worldwide. The shift from passive to empowered and self-aware customers is driving the genetic testing market. The inherent accessibility of direct-to-consumer genetic testing (DTC-GT) is a major advantage, giving consumers free access to their genetic information and personalized insights and recommendations. Many industries are seeing a significant increase in customers seeking tailored products and experiences, with an increased willingness to pay to identify and meet individual needs.

Genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the condition. The role of genetic testing in all areas of medicine is rapidly increasing. Genetic testing is already speeding up diagnoses, and it aids in identifying people with a genetic predisposition to highly resilient diseases. Preconception and prenatal genetic testing assist potential patients with reproductive decisions by informing them of their carrier status for genetic disorders.

The increasing awareness of the importance of genetic variations across a wide range of phenotypes associated with different diseases is further expected to promote market growth. These tests reveal whether a person has a genetic predisposition to a particular disease or phenotype of concern, which can be diagnosed as early as possible to initiate the disease treatment. The first sequencing of the human genome and advances in genome sequencing technology have enabled rapid growth in genomics research. This has also led to direct-to-consumer genetic testing becoming a new service. The Europe direct-to-consumer genetic testing market has influenced many people as these tests provide valid information about various health risks, personal characteristics, and overall well-being. Further, the rapid transition of the clinical laboratory workforce to DTC-GT is another crucial factor driving the market. For example, according to MIT Technology Review, approximately 8%, or nearly 26 million, people in the US took DNA tests in 2019. That number is expected to rise to over 100 million in the coming years.

Thus, the growing awareness among the population regarding genetic testing drives the direct-to-consumer genetic testing market.

Europe Direct-to-Consumer Genetic Testing Market Overview

The Europe direct-to-consumer genetic testing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The regional market is expected to grow significantly in the coming years owing to the rising awareness regarding genetic tests, and rising prevalence of genetic disorders and cancer. The rising technological advancements in the past few years have opened numerous opportunities for the direct-to-consumer genetic testing market expansion. The development of customized testing kits for niche therapeutic areas and rising prevalence of chronic diseases benefits the direct-to-consumer genetic testing market in Germany. Moreover, genetics has become vital in clinical practices with an exponential drop in the cost of an individual's genome sequencing. Genetics provides doctors with valuable presymptomatic diagnostic and, in some cases, analytical tools, which can be used to manage diseases more effectively and take preventive actions. The exponential fall in the price of genome analysis tools also allows individuals to access their genetic profiles quickly and economically.

According to the German Cancer Research Center, breast cancer was diagnosed in nearly 69,000 women and 700-800 men in Germany in 2022. This makes breast cancer one of the most frequently occurring cancers in Germany. The government of Germany announced a plan to include Breast Cancer gene 1 (BRCA) genetic testing in the national cancer plan, which was initiated in 2008 with an aim to ensure women who are at a higher genetic risk of breast cancer are legally entitled to thorough screening and risk-reducing options. The increasing focus of the German government on regulating and creating awareness regarding genetic tests triggers the adoption of direct-to-consumer genetic tests across Germany.

Europe Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

Europe Direct-To-Consumer Genetic Testing Market Segmentation

The Europe direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the Europe direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the Europe direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the Europe direct-to-consumer genetic testing market is bifurcated into online and offline. The online segment held a larger share in 2022.

Based on country, the Europe direct-to-consumer genetic testing market is segmented Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe direct-to-consumer genetic testing market in 2022.

Ancestry Genomics Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the Europe direct-to-consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview

5. Europe Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - Europe Market Analysis

  • 6.1 Europe Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Europe Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 Germany: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 Germany: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Germany: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 Germany: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Germany: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 UK: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 UK: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 UK: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 UK: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 UK: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 France: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 France: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 France: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 France: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 France: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.7 Italy: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.8 Italy: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.8.1 Italy: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.8.2 Italy: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.8.3 Italy: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.9 Spain: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.10 Spain: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.10.1 Spain: Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.10.2 Spain: Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.10.3 Spain: Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.11 Rest of Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.12 Rest of Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.12.1 Rest of Europe Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.12.2 Rest of Europe Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.12.3 Rest of Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Europe Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Ancestry Genomics Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Genetic Technologies Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Myriad Genetics, Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Living DNA Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 23andMe Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Direct-to-Consumer Genetic Testing Market Segmentation
  • Table 2. Germany Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. UK Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. UK Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Italy Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Italy Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Italy Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Spain Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Spain Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Spain Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of Europe Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of Europe Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of Europe Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Organic Developments Done by Companies
  • Table 21. Inorganic Developments Done by Companies
  • Table 22. Glossary of Terms, Europe Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. Europe Direct-to-Consumer Genetic Testing Market Segmentation, By Country
  • Figure 2. Europe Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 3. Europe Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 6. Ancestry Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Nutrigenomics Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Predictive Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Whole Genome Sequencing: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Single Nucleotide Polymorphism Chips: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Targeted Analysis: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 17. Online Platform: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Offline Platform: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. Europe Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
  • Figure 21. Germany: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. UK: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. France: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Italy: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Spain: Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Rest of Europe Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)